Natixis Walgreens Boots Alliance, Inc. Transaction History

Natixis

$17.4 Billion
Q2 2024

A detailed history of Natixis transactions in Walgreens Boots Alliance, Inc. stock. As of the latest transaction made, Natixis holds 6,352 shares of WBA stock, worth $57,549. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,352

Previous 22,915 72.28%

Holding current value

$57,549

Previous $497,000 84.71%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.1 - $19.54 $200,412 - $323,641	-16,563 Reduced 72.28%	6,352 $76,000
Q1 2024 May 13, 2024	SELL	$20.51 - $26.65 $271,983 - $353,405	-13,261 Reduced 36.66%	22,915 $497,000
Q4 2023 Feb 13, 2024	SELL	$19.94 - $26.64 $597,522 - $798,294	-29,966 Reduced 45.31%	36,176 $944,000
Q3 2023 Nov 14, 2023	SELL	$20.9 - $30.85 $576,171 - $850,472	-27,568 Reduced 29.42%	66,142 $1.47 Million
Q2 2023 Aug 11, 2023	BUY	$28.37 - $36.31 $883,186 - $1.13 Million	31,131 Added 49.75%	93,710 $2.67 Million
Q1 2023 May 12, 2023	BUY	$32.33 - $37.71 $15,583 - $18,176	482 Added 0.78%	62,579 $2.16 Million
Q4 2022 Feb 24, 2023	SELL	$30.52 - $41.79 $2.89 Million - $3.96 Million	-94,656 Reduced 60.39%	62,097 $2.32 Million
Q4 2022 Feb 13, 2023	BUY	$30.52 - $41.79 $1.59 Million - $2.17 Million	52,034 Added 49.69%	156,753 $5.86 Million
Q3 2022 Nov 14, 2022	BUY	$31.4 - $42.04 $62,454 - $83,617	1,989 Added 1.94%	104,719 $3.29 Million
Q2 2022 Aug 12, 2022	SELL	$37.9 - $46.81 $10 Million - $12.4 Million	-264,013 Reduced 71.99%	102,730 $3.92 Million
Q1 2022 May 13, 2022	BUY	$44.77 - $54.33 $12.6 Million - $15.3 Million	280,861 Added 327.03%	366,743 $16.4 Million
Q4 2021 Feb 14, 2022	BUY	$43.72 - $52.25 $1.41 Million - $1.68 Million	32,194 Added 59.96%	85,882 $4.48 Million
Q3 2021 Nov 12, 2021	BUY	$45.58 - $51.78 $2.45 Million - $2.78 Million	53,688 New	53,688 $2.53 Million
Q2 2021 Aug 13, 2021	SELL	$50.84 - $56.8 $2.05 Million - $2.29 Million	-40,393 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$41.16 - $55.05 $2.46 Million - $3.28 Million	-59,659 Reduced 59.63%	40,393 $2.22 Million
Q4 2020 Feb 12, 2021	BUY	$33.52 - $44.1 $1.91 Million - $2.51 Million	56,993 Added 132.36%	100,052 $3.99 Million
Q3 2020 Nov 12, 2020	SELL	$34.67 - $43.16 $583,426 - $726,296	-16,828 Reduced 28.1%	43,059 $1.55 Million
Q2 2020 Aug 13, 2020	SELL	$38.35 - $47.02 $9.32 Million - $11.4 Million	-242,955 Reduced 80.23%	59,887 $2.54 Million
Q1 2020 May 14, 2020	SELL	$41.02 - $59.59 $480,795 - $698,454	-11,721 Reduced 3.73%	302,842 $13.9 Million
Q4 2019 Feb 14, 2020	SELL	$52.08 - $62.72 $11.5 Million - $13.9 Million	-221,759 Reduced 41.35%	314,563 $18.5 Million
Q3 2019 Nov 13, 2019	BUY	$49.29 - $58.06 $15.3 Million - $18 Million	310,565 Added 137.57%	536,322 $29.7 Million
Q2 2019 Aug 13, 2019	SELL	$49.34 - $63.49 $9.12 Million - $11.7 Million	-184,739 Reduced 45.0%	225,757 $12.3 Million
Q1 2019 May 15, 2019	BUY	$59.79 - $74.43 $24.5 Million - $30.6 Million	410,496 New	410,496 $25.7 Million
Q4 2018 Feb 14, 2019	SELL	$65.26 - $85.69 $13.2 Million - $17.3 Million	-201,873 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$60.76 - $73.81 $10.7 Million - $13 Million	-175,912 Reduced 46.56%	201,873 $14.7 Million
Q2 2018 Aug 14, 2018	BUY	$59.7 - $68.0 $20.6 Million - $23.5 Million	345,021 Added 1053.05%	377,785 $22.7 Million
Q1 2018 May 15, 2018	SELL	$65.43 - $80.27 $6.42 Million - $7.88 Million	-98,112 Reduced 74.97%	32,764 $2.15 Million
Q4 2017 Feb 14, 2018	BUY	$64.48 - $76.95 $8.44 Million - $10.1 Million	130,876 New	130,876 $9.5 Million
Q3 2017 Nov 14, 2017	SELL	$77.22 - $82.74 $9.84 Million - $10.5 Million	-127,456 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	127,456	127,456 $9.98 Million

Others Institutions Holding WBA

# of Institutions

1,073

Shares Held

512M

Call Options Held

19.7M

Put Options Held

24.4M

View Full List

About Walgreens Boots Alliance, Inc.

Ticker WBA
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 864,812,992
Market Cap $7.84B
Description
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...

More about WBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account